000 01126 a2200325 4500
005 20250517233753.0
264 0 _c20190930
008 201909s 0 0 eng d
022 _a2168-6084
024 7 _a10.1001/jamadermatol.2018.2526
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaye, Alex
245 0 0 _aDupilumab for the Treatment of Recalcitrant Bullous Pemphigoid.
_h[electronic resource]
260 _bJAMA dermatology
_c10 2018
300 _a1225-1226 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aDermatologic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPemphigoid, Bullous
_xdrug therapy
700 1 _aGordon, Samantha C
700 1 _aDeverapalli, Sandhya C
700 1 _aHer, Min Ji
700 1 _aRosmarin, David
773 0 _tJAMA dermatology
_gvol. 154
_gno. 10
_gp. 1225-1226
856 4 0 _uhttps://doi.org/10.1001/jamadermatol.2018.2526
_zAvailable from publisher's website
999 _c28762353
_d28762353